Ligand Pharmaceuticals Inc (LGND)
EBITDA Margin
113.86%
Quarterly · Period ending:
LGND EBITDA Margin
Latest reported113.86%period ending
Latest reported113.86%period ending
LGND Quarterly EBITDA Margin (-226.09% → 113.86%)
Quarterly ebitda margin
High-resolution chart · PNG
LGND ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -33.3352% | |
| -39.1488% | |
| -112.1406% | |
| -86.4623% | |
| -88.664% | |
| -61.1106% | |
| -120.1613% | |
| -112.602% | |
| -159.5238% | |
| -93.2039% | |
| -502.3256% | |
| -387.1795% | |
| -327.2727% | |
| -211.7647% | |
| 3.6697% | |
| -76.4706% | |
| -71.7172% | |
| -69.3878% | |
| -84.375% | |
| -23.7624% | |
| -90.5882% | |
| -56.8182% | |
| -78.481% | |
| -103.0303% | |
| 100% | |
| -73.913% | |
| -70.8333% | |
| -118.9189% | |
| -216% | |
| -226.087% |